China starts up drug-recall system

Lately, not a week passes without China's trumpeting a new drug-safety initiative, and this week is no exception. Now, the country says it's launching a nationwide drug recall system. The news comes on the heels of a drug-and-device safety pact with the U.S., signed into being just yesterday. The recall plan will force pharma companies to withdraw problem products within 24 hours if the pose major safety concerns. If companies voluntarily recall bad drugs, they may escape fines and other punishments.

Meanwhile, China has also cracked down on the manufacturer of a tainted leukemia drug by pulling its production license. Shanghai Hualian Pharmaceutical also saw revenues from the drug seized, and company officials were taken into custody.

- check out the AP article
- read more on Shanghai Hualian's punishment
- read about the safety pact from The New York Times 

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

After a jury ordered Gilead's Kite Pharma to pay $752 million for CAR-T patent infringement, BMS is asking for punitive damages in that amount, too.